Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Camiel Göbel

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Trends in Immunology|November 8, 2025
Epigenetically programmed identity crisis to combat diffuse large B cell lymphomaRachele Niccolai, Camiel Göbel, Heinz Jacobs
Journal of Chromatography. A|June 7, 2016
Quantification of active infliximab in human serum with liquid chromatography-tandem mass spectrometry using a tumor necrosis factor alpha -based pre-analytical sample purification and a stable isotopic labeled infliximab bio-similar as internal standard: A target-based, sensitive and cost-effective methodMohsin El Amrani, Marcel P H van den Broek, Camiel Göbel, et al.
Journal of Translational Autoimmunity|August 4, 2020
Quantification of neutralizing anti-drug antibodies and their neutralizing capacity using competitive displacement and tandem mass spectrometry: Infliximab as proof of principleMohsin El Amrani, Camiel Göbel, Annelies C Egas, et al.
Pharmaceutics|May 27, 2023
Optimization of a Quantitative Anti-Drug Antibodies against Infliximab Assay with the Liquid Chromatography-Tandem Mass Spectrometry: A Method Validation Study and Future PerspectivesErin H Smeijsters, Kim C M van der Elst, Amy Visch, et al.
Blood|May 29, 2026
DOT1L Shapes ncPRC1-Target Gene Repression to Maintain Germinal Center B Cell Identity of Diffuse Large B cell LymphomaCamiel Göbel, Rachele Niccolai, Sebastian Gregoricchio, et al.
Neoplasia (New York, N.Y.)|October 28, 2025
Cholesterol biosynthesis as a drug-induced vulnerability in diffuse large B cell lymphoma insensitive to EZH2 inhibitionRachele Niccolai, Camiel Göbel, Klevis Ndoj, et al.
Blood|January 10, 2025
Targeting DOT1L and EZH2 synergizes in breaking the germinal center identity of diffuse large B-cell lymphomaCamiel Göbel, Rachele Niccolai, Marnix H P de Groot, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Trends in Immunology|November 8, 2025
Epigenetically programmed identity crisis to combat diffuse large B cell lymphomaRachele Niccolai, Camiel Göbel, Heinz Jacobs
Journal of Chromatography. A|June 7, 2016
Quantification of active infliximab in human serum with liquid chromatography-tandem mass spectrometry using a tumor necrosis factor alpha -based pre-analytical sample purification and a stable isotopic labeled infliximab bio-similar as internal standard: A target-based, sensitive and cost-effective methodMohsin El Amrani, Marcel P H van den Broek, Camiel Göbel, et al.
Journal of Translational Autoimmunity|August 4, 2020
Quantification of neutralizing anti-drug antibodies and their neutralizing capacity using competitive displacement and tandem mass spectrometry: Infliximab as proof of principleMohsin El Amrani, Camiel Göbel, Annelies C Egas, et al.
Pharmaceutics|May 27, 2023
Optimization of a Quantitative Anti-Drug Antibodies against Infliximab Assay with the Liquid Chromatography-Tandem Mass Spectrometry: A Method Validation Study and Future PerspectivesErin H Smeijsters, Kim C M van der Elst, Amy Visch, et al.
Blood|May 29, 2026
DOT1L Shapes ncPRC1-Target Gene Repression to Maintain Germinal Center B Cell Identity of Diffuse Large B cell LymphomaCamiel Göbel, Rachele Niccolai, Sebastian Gregoricchio, et al.
Neoplasia (New York, N.Y.)|October 28, 2025
Cholesterol biosynthesis as a drug-induced vulnerability in diffuse large B cell lymphoma insensitive to EZH2 inhibitionRachele Niccolai, Camiel Göbel, Klevis Ndoj, et al.
Blood|January 10, 2025
Targeting DOT1L and EZH2 synergizes in breaking the germinal center identity of diffuse large B-cell lymphomaCamiel Göbel, Rachele Niccolai, Marnix H P de Groot, et al.
Pageof 1